the global collaborative research initiative will initially target Alzheimer’s, Parkinson’s, Huntington’s disease, ALS, and Lewy body dementia

At the Allen Institute, we do science differently. We take on some of the biggest questions in biology at a scale designed to generate knowledge the world can use. We advance discovery through large-scale research initiatives called accelerators, bringi...

The Washington State Senate and House of Representatives convene in the House Floor Chamber to receive Gov. Bob Ferguson's State-of-the-State address.

New research reveals how early brains form and the critical periods that could help diagnose and treat brain disease.

Science has been a driving force behind major advances in health, technology, and the quality of our everyday lives. From life-saving medical treatments to innovations that shape our daily experiences...

The seven-year study reveals early-warning signs that could help doctors catch the disease before it starts, potentially saving patients years of pain and disability.

A new view of Parkinson’s disease

Norris Hall’s experience and insight into financial operations will help enable and propel transformative science at the Allen Institute.

For the first time ever, scientists have developed a precise genetic toolkit that can target the exact nerve cells destroyed by ALS—a discovery that...

In 1984, Dr. Daniel Drucker, an endocrinologist from the University of Toronto, discovered a hormone that helped pave the way for popular diabetes drugs such as Ozempic.

This data release features neuropathology images from the Seattle Alzheimer’s Disease Brain Cell Atlas (SEA-AD) project for two new brain regions of interest: Superior Temporal Gyrus (STG) and Prefron...